Michael Scolaro

Michael Scolaro

Oct 28, 2017

Group 6 Copy 39
1
Please wait...

About This Project

We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Blast off!

Browse Other Projects on Experiment

Related Projects

Next Generation Non-Seeing Eye Prosthesis

This project aims to push the current state of the art in ocular prothestics by integrating a small system of...

Can we use our immune cells to fight lung disease?

Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

Backer Badge Funded